Skip to content

Clinical trials

Musculoskeletal Diseases trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Phase: Not applicable Clear all

368 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20054
20061
20071
20095
20103
20118
20124
20138
201414
201512
201615
201718
201826
201921
202018
202137
202246
202333
202428
202532
202623

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed211
Unknown status58
Recruiting40
Not yet recruiting19
Active, not recruiting15
Terminated10
Withdrawn10
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Research Centre for the Working Environment, Denmark13
Afyonkarahisar Health Sciences University9
Chinese University of Hong Kong7
University of Texas at Austin7
Istituto Ortopedico Rizzoli4
Laval University4
McGill University4
Norwegian University of Science and Technology4
VA Office of Research and Development4
Bakirkoy Dr. Sadi Konuk Research and Training Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases368
Joint Diseases39
Osteoarthritis30
Arthritis23
Rheumatic Diseases23
Musculoskeletal Pain22
Pain22
Neck Pain18
Osteoarthritis, Knee18
Chronic Pain13

Trials

Showing 76 to 100 of 368. Each trial links to its page on Pharma Observatory.

268 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.